cervical cancer

Oncgnostics also expects the test to be approved by regulators in Canada and to be sold there by the end of the year.

The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia.

Hologic designed its scalable AI-based cytology platform to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.

Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.

The supplement adds a collection vial to the BD Onclarity test and includes performance data for the BD Viper LT and the BD COR Systems.

The test detects the presence of two biomarkers within a single cell associated with HPV infections that can progress to cervical cancer.

The expanded test can be used for genotype risk-based patient monitoring to prevent over-treatment, BD has said.